RMD
US EQUITY
Health Care
Health Care Equipment
CIK: 943819
ResMed (RMD) Quant Factor Diagnostic & Fair Value Model
ResMed (Ticker: RMD) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$252.86
-0.08%
Latest Close (2026-10-23)
Market Cap: $35.56B
P/E Ratio: 6.1
Momentum Strength
3M / 12M
+24.51%
1M: +13.96%
12M: -5.11%
Quality (ROE)
Point-in-Time
+92.53%
Trailing Return on Equity
Technical Trend
RSI 14
86.3
SMA50: $229.53
SMA200: $225.08
Valuation Multiplier
Trailing
6.1
Deep Value (Under 15x P/E)
📊
Valuation & Multi-Factor Diagnostic
Deep Value (Under 15x P/E)
RMD trades at an attractive earnings multiple of 6.1x, significantly lower than the broader S&P 500 average.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 5/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 943819 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-K | 2026-06-30 | 2026-08-13 | - | $1.52B | $1.81B | $10.43 |
| 10-K | 2025-06-30 | 2026-08-13 | - | $1.40B | $1.75B | $9.51 |
| 10-K | 2024-06-30 | 2026-08-13 | - | $1.02B | $1.40B | $6.92 |
| 10-Q | 2026-03-31 | 2026-05-01 | - | $398.73M | $1.35B | $2.74 |
| 10-Q | 2025-12-31 | 2026-05-01 | - | $392.59M | $797.07M | $2.68 |
| 10-Q | 2025-09-30 | 2026-05-01 | - | $348.54M | $457.32M | $2.37 |
| 10-Q | 2025-06-30 | 2026-05-01 | - | - | - | - |
| 10-Q | 2025-03-31 | 2026-05-01 | - | $365.04M | $1.21B | $2.48 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding ResMed (RMD) valuation multiples, momentum factors, and point-in-time filing conventions.
How should RMD's current valuation multiple be interpreted? ↓
RMD trades at a trailing P/E of 6.1x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are RMD's key momentum and technical factor indicators? ↓
As of the latest close, RMD shows a 1-month return of +13.96%, 3-month return of +24.51%, and 12-month return of -5.11%, with a 14-day RSI of 86.3. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for RMD? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can RMD be incorporated into systematic factor models? ↓
RMD can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.